Basic information Solubility Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Inhibitors >  LOXO-101 (sulfate)

LOXO-101 (sulfate)

Basic information Solubility Safety Supplier Related

LOXO-101 (sulfate) Basic information

Product Name:
LOXO-101 (sulfate)
Synonyms:
  • LOXO-101 (sulfate)
  • (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate (1:1)
  • Larotrectinib/LOXO 101/ARRY 470 sulfate
  • (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate
  • ARRY 470) sulfate
  • Larotrectinib sulfate
  • Larotrectinib(LOXO 101
  • Larotrectinib (LOXO-101) sulfate
CAS:
1223405-08-0
MF:
C21H24F2N6O6S
MW:
526.52
EINECS:
232-655-5
Product Categories:
  • API
  • LOXO-101
Mol File:
1223405-08-0.mol
More
Less

LOXO-101 (sulfate) Chemical Properties

storage temp. 
Store at -20°C
solubility 
≥18.47 mg/mL in DMSO; ≥2.14 mg/mL in EtOH; ≥29.65 mg/mL in H2O
form 
solid
Stability:
Hygroscopic
More
Less

LOXO-101 (sulfate) Usage And Synthesis

Solubility

LOXO-101 (sulfate)  can be dissolved in DMSO(Slightly), Methanol (Slightly, Sonicated), Water (Slightly) .

Description

LOXO-101 (sulfate) is an orally bioavailable, potent, ATP-competitive inhibitor of TRKA, TRKB, and TRKC. LOXO-101 has IC50 values in the low nanomolar range for inhibition of all three TRK family members in binding and cellular assays, with 100x selectivity over other kinases, and has shown acceptable pharmaceutical properties and safety in nonclinical models. The TRK family of neurotrophin receptors, TRKA, TRKB, and TRKC (encoded by NTRK1, NTRK2, and NTRK3 genes, respectively) and their neurotrophin ligands regulate growth, differentiation and survival of neurons.

Uses

Larotrectinib Sulfate is a potent and selective oral ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).

in vitro

in previous study, loxo-101 was evaluated for off-target kinase enzyme inhibition against a panel of non-trk kinases at a concentration of 1,000 nm and atp concentrations around the km. results showed that loxo-101 had greater than 50% inhibition for only one non-trk kinase, which was tnk2 with ic50 of 576 nm. moreover, there were neither relevant herg inhibition nor prolonged qt observation [1].

in vivo

animal study found that loxo-101 was able to inhibit in vivo tumor growth. athymic nude mice injected with km12 cells were orally treated with loxo-101 daily for 2 weeks, and dose-dependent tumor inhibition was observed, indicating the ability of loxo-101 to inhibit in-vivo tumor growth [1].

IC 50

low nanomolar range for inhibition of all trk family members

References

[1] doebele rc et al. an oncogenic ntrk fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor loxo-101. cancer discov.2015 oct;5(10):1049-57.

LOXO-101 (sulfate)Supplier

Shanghai Subo Pharmaceutical Technology Co., Ltd. Gold
Tel
021-54156369 16621315851
Email
yhsuyiming@126.com
Chunchuang (Wuhan) Technology Co., Ltd Gold
Tel
15342225168
Email
yutianchun2007@126.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Chembest Research Laboratories Limited
Tel
021-20908456
Email
sales@BioChemBest.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
More
Less

LOXO-101 (sulfate)(1223405-08-0)Related Product Information